This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity or ...

Higher doses of weight loss medications like Ozempic and Wegovy could help treat obesity. In two new studies, people taking 7 ...

Under brand names like Wegovy and Ozempic, semaglutide assists weight loss and manages diabetes through a series of daily ...

Data from two studies show greater weight loss and comparable safety with a higher dose of semaglutide for those with and ...

Hospital trips tied to semaglutide—the active ingredient in Ozempic and Wegovy—are rare, but can be serious, a new study found Compounded versions of semaglutide could explain some of these visits, ...

Semaglutide (better known as Wegovy) may help people with obesity lose up to 25% of their body weight when used at a higher ...

A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and related health outcomes in adults ...

The STEP UP trial reveals semaglutide 7.2 mg significantly reduces weight compared to 2.4 mg, though it raises questions ...

Trial participants who received an increased weekly dose of Wegovy lost 19 per cent of their body weight in a year on average ...

"For them to work effectively, they need to be taken long term," cautioned epidemiologisy professor Reimar W. Thomsen.

A higher dose of the weight loss drug semaglutide (better known by its brand name Wegovy) may help people lose up to 25% of ...

Simon Spichak finished his MSc at University College Cork, where he studied the interactions between the microbes in the gut and the brain. He became interested in science communication during his ...